Advertisement

Dopamine Agonist and Antagonist Drugs and Hypothalamic Pituitary Dysfunction

  • Eugenio E. Müller
  • Franco Camanni
  • Andrea R. Genazzani
  • Daniela Cocchi
  • Felipe Casanueva
  • Ferdinando Massara
  • Vittorio Locatelli
  • Abraham Martinez-Campos
  • Paolo Mantegazza

Abstract

It is now well established that a family of neuropeptides, the hypothalamic releasing and inhibiting or regulatory hormones, produced in neural cell bodies, regulate the secretory activity of the anterior pituitary (AP) gland. They are secreted at the level of the median eminence (ME) into the primary plexus of the hypophysial-portal blood vessels and are then vehicled to the AP cells, where they stimulate or inhibit the synthesis and release of AP hormones.

Keywords

Dopamine Agonist Median Eminence Ergot Alkaloid Antagonist Drug TIDA Neuron 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahn, H.S., Gardner, E. and Makman, M.H. (1979). Erop. J. Pharmacol., 53, 313CrossRefGoogle Scholar
  2. Apud, J., Cocchi, D., Iuliano, E., Müller, E.E. and Racagni, G. (1980). Brain Res., 168, 226CrossRefGoogle Scholar
  3. Beck, W., Hancke, J.L. and Wuttke, W. (1978). Endocrinology 102, 837PubMedCrossRefGoogle Scholar
  4. Belforte, L., Camanni, F., Chiodini, P.G., Liuzzi, A., Massara, F., Molinatti, G.M., Müller, E.E. and Silvestrini, F. (1977). Acta Endocrinol. (Kbh.) 85, 235Google Scholar
  5. Ben-Jonathan, N., Oliver, C., Weiner, H.J., Mical, R.S. and Porter, J.C. (1977). Endocrinology 100, 452PubMedCrossRefGoogle Scholar
  6. Bergh, T., Nillius, S.J. and Wide, L. (1978). Br. Med. J., 1, 875PubMedCrossRefGoogle Scholar
  7. Bergland, R.M. (1979). Lancet ii, 1270Google Scholar
  8. Besser, G.M. (1978). Med. J. aust., 2 (suppl.), 14PubMedGoogle Scholar
  9. Boyd, A.E., Lebovitz, H.G. and Pfeiffer, J.G. (1970). N. Eng. J. Med., 283, 1425CrossRefGoogle Scholar
  10. Brawer, J.R., Naftolin, P., Martin, J. and Sonneschein, C. (1978). Endocrinology 103, 501PubMedCrossRefGoogle Scholar
  11. Camanni, F., Massara, F., Belforte, L., Rosatello, A. and Molinatti, G.M. (1977). J. Clin. Endocrinol. Metab., 44, 465PubMedCrossRefGoogle Scholar
  12. Camanni, F., Picotti, G.B., Massara, F., Molinatti, G.M., Mantegazza, P. and Müller, E.E. (1978). J. Clin. Endocrinol. Metab., 47, 647PubMedCrossRefGoogle Scholar
  13. Camanni, F., Genazzani, A.R., Massara, F., La Rosa, R., Cocchi, D. and Müller, E.E. (1980). Neuroendocrinology 30, 2PubMedCrossRefGoogle Scholar
  14. Carlsson, A. (1975). In Pre-and Postsynaptic Receptors, ed. E. Usdin and W.E. Bunney ( Dekker, New York ) p. 49Google Scholar
  15. Chiodini, P.G., Liuzzi, A., Botalla, L., Cremascoli, G. and Silvestrini, F. (1974). J. Clin. Endocrinol. Metab., 38, 200PubMedCrossRefGoogle Scholar
  16. Chiodini, P.G., Liuzzi, A., Müller, E.E., Botalla, L., Cremascoli, G., Oppizzi, G., Verde, G. and Silvestrini, F. (1976). J. Clin. Endocrinol. Metab., 43, 356PubMedCrossRefGoogle Scholar
  17. Cocchi, D., Locatelli, V., Picciolini, E., Genazzani, A.R. and Müller, E.E. (1979). Proc. Soc. Exp. Biol. Med. (NY) 162, 38Google Scholar
  18. Cocchi, D., Gil-Ad, I., Parenti, M., Stefanini, E., Locatelli, V. and Müller, E.E. (1980). Neuroendocrinology 30, 65PubMedCrossRefGoogle Scholar
  19. Cohen, H.N., Hay, I.D., Beastall, G.H. and Thompson, J.A. (1979a). Clin. Endocrinol., 11, 95CrossRefGoogle Scholar
  20. Cohen, H.N., Hay, I.D., Thompson, J.A., Logue, F., Racliffe, W.A. and Beastall, G.H. (1979b). Clin. Endocrinol., 11, 89CrossRefGoogle Scholar
  21. Collu, R., Leboeuf, G., Letarte, J. and Ducharme, J.R. (1975). Pediatrics 56, 262Google Scholar
  22. Coulman, C.B., Annegers, J.F., Abbond, C.F., Laws, E.R. and Kurland, L.T. (1979). Fert. Ster., 32,28 92 Dopamine Agonist and Antagonist Drugs Google Scholar
  23. Cowden, E.A., Thomson, J.A., Doyle, D., Ratcliffe, J.G., Macpherson, P. and Teasdale, G.M. (1979). Lancet i, 1155Google Scholar
  24. Cramer, O.M., Parker, C.R. and Porter, J.C. (1979). Endocrinology 105, 419CrossRefGoogle Scholar
  25. Creese, I., Burt, D.R. and Snyder, S.R. (1975). Life Sci., 17, 993CrossRefGoogle Scholar
  26. Crosignani, P.G., Lombroso, G.C., Caccamo, A., Reschini, E. and Peracchi, M. (1978a). Obst. Gynec., 51, 113Google Scholar
  27. Crosignani, P.G., Peracchi, M., Lombroso, G.C., Reschini, E., Mattei, A., Caccamo, A. and D’Alberton, A. (1978b). Am. J. Obst. Gynec., 132, 307Google Scholar
  28. Crosignani, P.G., Ferrari, C., Fadini, R., Meschia, M., Picciotti, M.C. and Reschini, E. (1980). In Neuroactive Drugs in Endocrinology, ed. E.E. Müller ( Elsevier/North-Holland, Amsterdam ) p. 341Google Scholar
  29. Daughaday, W.H. (1977). New Eng. Med. J., 297, 12Google Scholar
  30. De Camilli, P., Macconi, D. and Spada, A. (1979). Nature (Lond.) 287, 252Google Scholar
  31. Faglia, G., Beck-Peccoz, P., Ambrosi, B., Travaglini, P., Moriondo, P., Elli, R. and Rondena, M. (1980a). In Pituitary Microadenomas, ed. G. Faglia, M. Giovannelli and R.M. MacLeod ( Academic Press, New York ) p. 277Google Scholar
  32. Faglia, G., Moriondo, P., Beck-Poccoz, P., Travaglini, P., Ambrosi, B., Spada, A. and Nissim, M. (1980b). In Neuroactive Drugs in Endocrinology, ed. E.E. Millier ( Elsevier/NorthHolland, Amsterdam ) p. 263Google Scholar
  33. Ferrari, C., Caldara, R., Rampini, P., Telloli, P., Romussi, M., Bertazzoni, A., Polloni, G., Mattei, A. and Crosignani, P.G. (1978). Metabolism 27, 1499PubMedCrossRefGoogle Scholar
  34. Ferrari, C., Crosignani, P.G., Caldara, R., Picciotti, M.C., Malinverni, A., Barattini, B., Rampini, P. and Telloli, P. (1980). J. Clin, Endocrinol. Metab., S0, 23CrossRefGoogle Scholar
  35. Mendelson, J.H., Ellingboe, J., Kuehnle, J. and Mello, N.K. (1978). J. Pharmacol. Exp. Ther., 207, 611PubMedGoogle Scholar
  36. Flückiger, E. and Wagner, H.R. (1968). Experientia (Basel) 24, 1130Google Scholar
  37. Fuxe, K., Hökfelt, T., Jonsson, G. and Löfström, A. (1974). In Neurosecretion — The Final Neuroendocrine Pathways, ed. F. Knowles and L. Volrath ( Springer Verlag, Berlin ) p. 269Google Scholar
  38. Fuxe, K., Eneroth, P., Gustafson, J.A., Lofström, A. and Skett, P. (1977). Brain Res., 122, 177 Google Scholar
  39. Gil-Ad, I., Locatelli, V., Cocchi, D., Carminati, R., Arezzini, C. and Müller, E.E. (1978). Life Sci., 23, 2245PubMedCrossRefGoogle Scholar
  40. Gomez-Sanchez, C. and Kaplan, N.M. (1972). J. Clin. Endocrinol. Metab., 34, 1105PubMedCrossRefGoogle Scholar
  41. Green, J.D. and Harris, G.W. (1947). J. Endocrinol., 5, 136PubMedCrossRefGoogle Scholar
  42. Griffith, R.W., Turkaly, I. and Brown, P. (1978). Brit. J. Clin. Pharm., 5, 227PubMedGoogle Scholar
  43. Guyda, H., Robert, F., Colle, E. and Hardy, J. (1973). J. Clin. Endocrinol. Metab., 36, 531PubMedCrossRefGoogle Scholar
  44. Hardy, J. (1975). In Progress in Neurological Surgery, ed. H. Krayenbühl, P.E. Maspes and W.H. Sweet (S. Karger, Basel ) p. 200Google Scholar
  45. Hayek, A. and Crawford, J.D. (1972). J. Clin. Endocrinol. Metab., 34, 764PubMedCrossRefGoogle Scholar
  46. Hökfelt, T. (1974). Fed. Proc., Fed. Am. Soc. Exp. Biol., 33, 2177Google Scholar
  47. Hruska, R.E. and Silbergeld, E.K. (1980). Europ. J. Pharmacol., 61, 397CrossRefGoogle Scholar
  48. hie, M. and Thushima, T.J. (1972). J. Clin. Endocrinol. Metab., 35, 97CrossRefGoogle Scholar
  49. Kebabian, J.W. and Calne, D.B. (1978). Nature (Lond.) 277, 93Google Scholar
  50. Kizer, J.S., Palkovits, M. and Brownstein, M. (1976). Brain Res., 108, 363PubMedCrossRefGoogle Scholar
  51. Kleimberg, D.L. Noel, G.L. and Frantz, A.G. (1977). N. Eng. J. Med., 296, 589CrossRefGoogle Scholar
  52. Köbberling, J., Schwinn, G., Mayer, G. and Dirks, H. (1980). In Neuroactive Drugs in Google Scholar
  53. Endocrinology,ed. E.E. Müller (Elsevier/North-Holland, Amsterdam) p. 315 Krieger, D.T. and Glick, S.M. (1972). Am. J. Med., 53,25Google Scholar
  54. Kumakura, K., Hoffman, M., Cocchi, D., Trabucchi, M., Spano, P.F. and Müller, E.E. (1979). Psychopharmacology 71, 13CrossRefGoogle Scholar
  55. Lachelin, G.C.L., Abu-Fadil, S. and Yen, S.S.C. (1977a). J. Clin. Endocrinol. Metab., 44, 1163PubMedCrossRefGoogle Scholar
  56. Lachelin, G.C.L., Leblanc, H. and Yen, S.S.C. (1977b), J. Clin. Endocrinol. Metab., 44, 728PubMedCrossRefGoogle Scholar
  57. Mendelson, J.H., Ellingboe, J., Kuehnle, J. and Mello, N.K. (1978). J. Pharmacol. Exp. Ther., 207, 611PubMedGoogle Scholar
  58. Lamberts, S.W., Klijn, J.C.M., de Quijada, M., Timmermans, H.A.T., Uitterlinden, P. and Birkenhäger, J.C. (1980a). In Neuroactive Drugs in Endocrinology, ed. E.E. Müller ( Elsevier/North-Holland, Amsterdam ) p. 371Google Scholar
  59. Lamberts, S.W.J., MacLeod, R.M. and Krieger, D. (1980b). In Pituitary Microadenomas, ed. G. Faglia, M. Giovanelli and R.M. MacLeod ( Academic Press, New York ) p. 151Google Scholar
  60. Lemberger, L. and Crabtree, R.E. (1979). Science 205, 1151PubMedCrossRefGoogle Scholar
  61. Liuzzi, A., Panerai, A.E., Chiodini, P.G., Secchi, C., Cocchi, D., Botalla, L., Silvestrini, F. and Müller, E.E. (1976). In Growth Hormone and Related Peptides, ed. A. Pecile and E.E. Müller ( Excerpta Medica, Amsterdam ) p. 236Google Scholar
  62. Liuzzi, A., Chiodini, P.G., Oppizzi, G., Botalla, L., Verde, G., De Stefano, L., Colussi, G., Graf, K.J. and Horowski, R. (1978). J. Clin. Endocrinol. Metab., 46, 196PubMedCrossRefGoogle Scholar
  63. MacLeod, R.M. (1976). In Frontiers in Neuroendocrinology, ed. L. Martini and W.F. Ganong ( Raven Press, New York ) p. 169Google Scholar
  64. MacLeod, R.M. and Krieger, D.T. (1976). Abstract 317, Fifty-eighth Annual Meeting of the Endocrinological Society, (San Francisco)Google Scholar
  65. McNatty, K.P., McNeilly, A.S. and Sawers, R.S. (1977). In Prolactin and Human Repro-duction, ed. P.G. Crosignani and C. Robyn ( Academic Press, New York ) p. 109Google Scholar
  66. Malarkey, W.B., Jacobs, L.S. and Daughaday, W.H. (1971). New Engl. J. Med., 285, 1160PubMedCrossRefGoogle Scholar
  67. Mars, H. and Genuth, S.M. (1973). Clin. Pharmacol. Ther., 14, 390PubMedGoogle Scholar
  68. Moore, K.E., Demarest, K.T., Johnston, C.A. and Alper, R.H. (1980). In Neuroactive Drugs in Endocrinology, ed. E.E. Müller ( Elsevier/North-Holland, Amsterdam ) p. 109Google Scholar
  69. Moriondo, P. Travaglini, P., Rondena, M., Beck-Peccoz, P., Conti-Puglisi, F., Ambrosi, B. and Faglia, G. (1980). In Pituitary Microadenomas, ed. G. Faglia, M. Giovanelli and R.M. MacLeod ( Academic Press, New York ) p. 247Google Scholar
  70. Müller, E.E. (1979). In Hormonal Proteins and Peptides, Vol. 7, ed. C.H. Li ( Academic Press, New York ) p. 123Google Scholar
  71. Müller, E.E., Genazzani, A.R., Murru, S. and Fioretti, P. (1977). Acta Endocrinol. (Kbh.) 86, 33Google Scholar
  72. Müller, E.E., Genazzani, A.R. and Murru, S. (1978a). J. Clin. Endocrinol. Metab., 47, 1352PubMedCrossRefGoogle Scholar
  73. Müller, E.E., Nisticb, G. and Scapagnini, U. (1978b). Brain Neurotransmitters and Anterior Pituitary Function, ( Academic Press, New York )Google Scholar
  74. Mendelson, J.H., Ellingboe, J., Kuehnle, J. and Mello, N.K. (1978). J. Pharmacol. Exp. Ther., 207, 611PubMedGoogle Scholar
  75. Peillon, F., Racadot, J., Moussy, D., Vila-Porcile, E., Olivier, L. and Racadot, O. (1978). In Treatment of Pituitary Adenomas, ed. R. Falbusch and K. von Werder ( Thieme, Stuttgart ) p. 114Google Scholar
  76. Pontiroli, A.E., Alberetto, M., Pellicciotta, G., De Castro e Silva, E., De Pasqua, A., Girardi, A.M. and Pozza, G. (1980). Acta Endocrinol (kbh.) 93, 271Google Scholar
  77. del Pozo, E. and Wolf, A. (1978). Triangolo 16 (suppl.), 43Google Scholar
  78. del Pozo, E., Wyss, H., Lancranjan, L., Obobensky, W. and Varga, L. (1976). In Ovulation in the Human, ed. P.G. Crosignani and D.R. Mishell ( Academic Press, London )Google Scholar
  79. Quadri, S.K., Lu, K.H. and Meites, J. (1972). Science 176, 417PubMedCrossRefGoogle Scholar
  80. Roth, R.H., Marrin, L.C. and Walters, J.R. (1976). Europ. J. Pharmacol., 36, 163 Schönberger, W., Grimm, W. and Ziegler, R. (1977). Europ. J. Pediatr., 127, 15Google Scholar
  81. Seppälä, M., Ranta, T. and Hirvonen, E. (1976). Lancet ii, 1154Google Scholar
  82. Sherman, B.M., Schlechte, J., Halmi, N.S., Chapler, F.K., Harris, C.E., Duello, T.M. Van Gilder, J. and Granner, D.K. (1978). Lancet ii, 1019Google Scholar
  83. Sowers, J.B., McCallum, R.W., Hershman, J.M., Carlson, H.E., Sturdevant, R.L. and Meyer, N. (1976). J. Clin. Endocrinol. Metab., 43, 679PubMedCrossRefGoogle Scholar
  84. Spano, P.F. and Trabucchi, M. (eds) (1978). Ergot Alkaloids. Pharmacology 16, suppl. 1 ( Karger, Basel )Google Scholar
  85. Spano, P.F., Trabucchi, M., Corsini, G.U. and Gessa, G.L. (eds) (1979). Sulpiride and Other Benzamides ( Italian Brain Research Foundation Press, Milan ).Google Scholar
  86. Swanson, H.A. and du Boulay, G. (1975). Brit. J. Radiol., 48, 366PubMedCrossRefGoogle Scholar
  87. Thomer, M.O., Ryan, S.M., Wass, J.A.H., Jones, A., Bouloux, P., Williams, S. and Besser, G.M. (1978). J. Clin. Endocrinol. Metab., 47, 372Google Scholar
  88. Thomer, M.O., Martin, W.H., Rogol, A.D., Morris, J.L. Perryman, R.L., Conway, B.R., Howards, S.S., Wolman, M.G. and MacLeod, R.M. (1980). J. Clin. Endocrinol. Metab., 51, 438CrossRefGoogle Scholar
  89. Tyrrel, J.B., Brooks, R.M., Ritzgerald, P.A., Cofold, P.B., Forshman, P.H. and Wilson, C.B. (1978). New Eng. J. Med., 298, 753CrossRefGoogle Scholar
  90. Van Loon, G.R., Appel, N.M., Kim, C. and Ho, D. (1980). In Neuroactive Drugs in Endocrinology, ed. E.E. Müller ( Elsevier/North-Holland, Amsterdam ) p. 279Google Scholar
  91. Varga, L., Lutterbeck, P.M., Pryor, J.S., Wenner, R. and Erg, H. (1972). Br. Med. J., 2, 743PubMedCrossRefGoogle Scholar
  92. Vezina, J.L. and Sutton, T.J. (1974). Am. J. Roentgenol. Radium Ther. Nucl. Med., 120, 46PubMedGoogle Scholar
  93. Wass, J.A.H., Thorner, M.O., Charlesworth, M., Moult, P.J.A., Dacie, J.E., Jones, A.E. and Besser, G.M. (1979). Lancet ii,66Google Scholar
  94. Weiner, R.J., Cronin, M.J., Cheung, C.T., Annunziato, L., Faure, N. and Goldsmith, P.C. (1979). In Neuroendocrine Correlates in Neurology and Psychiatry, ed. E.E. Müller and A. Agnoli ( Elsevier/North-Holland, Amsterdam ) p. 41Google Scholar
  95. Weldon, V.Y., Gupta, S.K., Haymond, M.W., Pagliara, A.S., Jacobs, L.S. and Daughaday, W.H. (1973). J. Clin, Endocrinol. Metab., 36, 42CrossRefGoogle Scholar
  96. von Werder, K., Eversmann, T., Falbusch, R. and Rjosk, H.K. (1980). In Neuroactive Drugs in Endocrinology, ed. E.E. Müller ( Elsevier/North-Holland, Amsterdam ) p. 347Google Scholar
  97. Wurtman, R. (1973). In Frontiers in Catecholamine Research, ed. E. Usdin and S.H. Snyder ( Pergamon Press, New York ) p. 781Google Scholar
  98. Zarate, A., Canales, E.S., Alger, M. and Forsbach, G. (1979). Acta Endocrinol. (Kbh.) 92, 407Google Scholar

Copyright information

© Pavel D. Hrdina and Radhey L. Singhal 1981

Authors and Affiliations

  • Eugenio E. Müller
  • Franco Camanni
  • Andrea R. Genazzani
  • Daniela Cocchi
  • Felipe Casanueva
  • Ferdinando Massara
  • Vittorio Locatelli
  • Abraham Martinez-Campos
  • Paolo Mantegazza

There are no affiliations available

Personalised recommendations